Biotech startups are pretty high maintenance. To achieve the common 10X + plus multiples, most new drugs take over 12-15 YRS and cost between $2-4 billion (YES, billion with a B) to bring to market. Medical devices come in at a slightly lower 🏷 $75-95 million and an average of 3-7 YRS. Digital health 👩🏽⚕️ remains the wild west 👢 with lower cost (avg. $13.8 M) of commercialization and regulatory hurdles 🚧 but with unproven returns despite impressive growth. For more fun facts on dev cycles, runways, and our kind of startups 🚀stay tuned for our infographic in the CBG journal.
Finding the right space can be a major hurdle many biotech companies face. The demands for CGMP and CLIA-certified wet lab space and expensive specialized equipment can be rate-limiting for startups. Come find out more about one of the top R&D incubators CUBEinc and hear from rockstar founders + innovators who currently call the space home. It's FREE, so why not come out?